J Korean Neurosurg Soc.  2018 Mar;61(2):233-242. 10.3340/jkns.2017.0405.001.

Spinal Cord Subependymoma Surgery: A Multi-Institutional Experience

Affiliations
  • 1Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea. chungc@snu.ac.kr
  • 2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Brain and Cognitive Sciences, Seoul National University College of Natural Science, Seoul, Korea.
  • 4Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 5Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 6Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 7Department of Neurosurgery, Kyungpook National University Hospital, Daegu, Korea.

Abstract


OBJECTIVE
A spinal cord subependymoma is an uncommon, indolent, benign spinal cord tumor. It is radiologically similar to a spinal cord ependymoma, but surgical findings and outcomes differ. Gross total resection of the tumor is not always feasible. The present study was done to determine the clinical, radiological and pathological characteristics of spinal cord subependymomas.
METHODS
We retrospectively reviewed the medical records of ten spinal cord subependymoma patients (M : F=4 : 6; median 38 years; range, 21-77) from four institutions.
RESULTS
The most common symptoms were sensory changes and/or pain in eight patients, followed by motor weakness in six. The median duration of symptoms was 9.5 months. Preoperative radiological diagnosis was ependymoma in seven and astrocytoma in three. The tumors were located eccentrically in six and were not enhanced in six. Gross total resection of the tumor was achieved in five patients, whereas subtotal or partial resection was inevitable in the other five patients due to a poor dissection plane. Adjuvant radiotherapy was performed in two patients. Neurological deterioration occurred in two patients; transient weakness in one after subtotal resection and permanent weakness after gross total resection in the other. Recurrence or regrowth of the tumor was not observed during the median 31.5 months follow-up period (range, 8-89).
CONCLUSION
Spinal cord subependymoma should be considered when the tumor is located eccentrically and is not dissected easily from the spinal cord. Considering the rather indolent nature of spinal cord subependymomas, subtotal removal without the risk of neurological deficit is another option.

Keyword

Subependymoma; Ependymoma; Spine; Spinal cord; Spinal cord neoplasms; Surgery

MeSH Terms

Astrocytoma
Diagnosis
Ependymoma
Follow-Up Studies
Glioma, Subependymal*
Humans
Medical Records
Radiotherapy, Adjuvant
Recurrence
Retrospective Studies
Spinal Cord Neoplasms
Spinal Cord*
Spine

Figure

  • Fig. 1 Preoperative magnetic resonance (MR) images showing an intramedullary mass located at the C2–7 level with associated hydrosyrinx extending to T3 level. A : Sagittal T1-weighted image without contrast showing isointense lesion. B : Sagittal T1-weighted image with contrast showing poor gadolinium enhancement. C : Sagittal T2-weighted image exhibiting hyperintense lesion. D : Axial T2-weighted image showing the mass located at left and dorsal side of the spinal cord. E : Postoperative T2-weighted image revealing partial removal state of the tumor.

  • Fig. 2 A : Intraoperative photograph after durotomy showing an edematous spinal cord rotated to right side. B : After myelotomy, the exposed tumor is gelatinous and light grayish with indistinct dissection plane.

  • Fig. 3 A : Hematoxylin and eosin (H&E) staining of resected specimens showing lobular architecture (H&E, ×20). B : Clustered nuclei (H&E, ×100). C : With focal degenerative nuclear enlargement or pleomorphism (H&E, ×200). D : Immunostaining of specimens showing diffuse positive to GFAP (GFAP immunostainig, ×150). E : Ki-67 index was less than 1% (Ki67, ×150). GFAP : glial fibrillary acidic protein.


Reference

References

1. Artico M, Bardella L, Ciappetta P, Raco A. Surgical treatment of subependymomas of the central nervous system. Acta Neurochir (Wien). 98:25–31. 1989.
Article
2. Bardella L, Artico M, Nucci F. Intramedullary subependymoma of the cervical spinal cord. Surg Neurol. 29:326–329. 1988.
Article
3. Bergman TA, Haines SJ. Subependymoma of the cervical spinal cord. A case report of long-term survival. Minn Med. 74:21–24. 1991.
4. Bi Z, Ren X, Zhang J, Jia W. Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. J Neurosurg. 122:49–60. 2015.
Article
5. Boström A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Boström JP, et al. Surgery for spinal cord ependymomas: outcome and prognostic factors. Neurosurgery. 68:302–309. 2011.
6. Boykin FC, Cowen D, Iannucci CA, Wolf A. Subependymal glomerate astrocytomas. J Neuropathol Exp Neurol. 13:30–49. 1954.
7. Bret P, Bougeard R, Saint-Pierre G, Guyotat J, Ricci AC, Confavreux C. Intramedullary subependymoma of the cervical spinal cord. Review of the literature a propos of a case. Neurochirurgie. 43:158–163. 1997.
8. Casey AT, Marsh H, Wilkins P. Subependymoma of the thoracic cord: potential pitfalls in diagnosis. Br J Neurosurg. 7:319–322. 1993.
Article
9. Cervos-Navarro J, Artigas J, Perez-Canto A. Clinical and immunohistological findings in subependymomas of the spinal cord. Verh Dtsch Ges Pathol. 70:376–379. 1986.
10. Cure LM, Hancock CR, Barrocas AM, Sternau LL, C Hirzel A. Interesting case of subependymoma of the spinal cord. Spine J. 14:e9–e12. 2014.
Article
11. Dario A, Fachinetti P, Cerati M, Dorizzi A. Subependymoma of the spinal cord: case report and review of the literature. J Clin Neurosci. 8:48–50. 2001.
Article
12. Dhandapani S, Anirudh S, Garg R, Vasishta RK, Vyas S. Subependymoma causing conus-cauda syndrome: cured by total excision. Neurol India. 61:675–677. 2013.
Article
13. Guha A, Resch L, Tator CH. Subependymoma of the thoracolumbar cord. Case report. J Neurosurg. 71(5 Pt 1):781–787. 1989.
14. Herrmann H-D, Neuss M, Winkler D. Intramedullary spinal cord tumors resected with CO2 laser microsurgical technique: recent experience in fifteen patients. Neurosurgery. 22:518–522. 1988.
Article
15. Hoeffel C, Boukobza M, Polivka M, Lot G, Guichard JP, Lafitte F, et al. MR manifestations of subependymomas. AJNR Am J Neuroradiol. 16:2121–2129. 1995.
16. Im SH, Paek SH, Choi YL, Chi JG, Kim DG, Jung HW, et al. Clinicopathological study of seven cases of symptomatic supratentorial subependymoma. J Neurooncol. 61:57–67. 2003.
17. Iwasaki M, Hida K, Aoyama T, Houkin K. Thoracolumbar intramedullary subependymoma with multiple cystic formation: a case report and review. Eur Spine J 22 Suppl. 3:S317–S320. 2013.
Article
18. Jabri HE, Dababo MA, Alkhani AM. Subependymoma of the spine. Neurosciences (Riyadh). 15:126–128. 2010.
19. Jain A, Amin AG, Jain P, Burger P, Jallo GI, Lim M, et al. Subependymoma: clinical features and surgical outcomes. Neurol Res. 34:677–684. 2012.
Article
20. Jallo GI, Zagzag D, Epstein F. Intramedullary subependymoma of the spinal cord. Neurosurgery. 38:251–257. 1996.
Article
21. Jang WY, Lee JK, Lee JH, Kim SH. Intramedullary subependymoma of the thoracic spinal cord. J Korean Neurosurg Soc. 39:385–388. 2006.
Article
22. Jin SH, Chung CK, Kim CH, Choi YD, Kwak G, Kim BE. Multimodal intraoperative monitoring during intramedullary spinal cord tumor surgery. Acta Neurochir (Wien). 157:2149–2155. 2015.
Article
23. Kim CH, Chung CK, Lee SH, Jahng TA, Hyun SJ, Kim KJ, et al. Long-term recurrence rates after the removal of spinal meningiomas in relation to simpson grades. Eur Spine J. 25:4025–4032. 2016.
Article
24. Kremer P, Zoubaa S, Schramm P. Intramedullary subependymoma of the lower spinal cord. Br J Neurosurg. 18:548–551. 2004.
Article
25. Krishnan SS, Panigrahi M, Pendyala S, Rao SI, Varma DR. Cervical Subependymoma: a rare case report with possible histogenesis. J Neurosci Rural Pract. 3:366–369. 2012.
Article
26. Lach B, Russell N, Benoit B. Atypical Subependymoma of the spinal cord: ultrastructural and immunohistochemical studies. Neurosurgery. 27:319–325. 1990.
Article
27. Lee KS, Angelo JN, McWhorter JM, Davis CH Jr. Symptomatic subependymoma of the cervical spinal cord. Report of two cases. J Neurosurg. 67:128–131. 1987.
28. Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, Kim KJ, et al. Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea spinal oncology research group. Neuro Oncol. 15:921–929. 2013.
Article
29. Matsumoto K, Nakagaki H. Intramedullary subependymoma occupying the right half of the thoracic spinal cord--case report. Neurol Med Chir (Tokyo). 42:349–353. 2002.
Article
30. Matsumura A, Hori A, Spoerri O. Spinal subependymoma presenting as an extramedullary tumor: case report. Neurosurgery. 23:115–117. 1988.
Article
31. McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 72:523–532. 1990.
Article
32. Nagashima M, Isu T, Iwasaki Y, Miyamachi K, Akino M, Abe H, et al. Intramedullary subependymoma of the cervical spinal cord. Case report. Neurol Med Chir (Tokyo). 28:303–308. 1988.
33. Nakasu S, Nakasu Y, Saito A, Handa J. Intramedullary subependymoma with neurofibromatosis--report of two case. Neurol Med Chir (Tokyo). 32:275–280. 1992.
34. Orakcioglu B, Schramm P, Kohlhof P, Aschoff A, Unterberg A, Halatsch ME. Characteristics of thoracolumbar intramedullary subependymomas. J Neurosurg Spine. 10:54–59. 2009.
Article
35. Pagni CA, Canavero S, Giordana MT, Mascalchi M, Arnetoli G. Spinal intramedullary subependymomas: case report and review of the literature. Neurosurgery. 30:115–117. 1992.
36. Pluchino F, Lodrini S, Lasio G, Allegranza A. Complete removal of holo-cord subependymoma. Case report. Acta Neurochir (Wien). 73:243–250. 1984.
37. Roeder MB, Jinkins JR, Bazan C 3rd. Subependymoma of filum terminale: MR appearance. J Comput Assist Tomogr. 18:129–130. 1994.
38. Salcman M, Mayer R. Intramedullary subependymoma of the cervical spinal cord: case report. Neurosurgery. 14:608–611. 1984.
Article
39. Salvati M, Raco A, Artico M, Artizzu S, Ciappetta P. Subependymoma of the spinal cord. Case report and review of the literature. Neurosurg Rev. 15:65–69. 1992.
Article
40. Shimada S, Ishizawa K, Horiguchi H, Shimada T, Hirose T. Subependymoma of the spinal cord and review of the literature. Pathol Int. 53:169–173. 2003.
Article
41. Slowik F, Pasztor E, Szöllösi B. Subependymal gliomas. Neurosurg Rev. 2:79–86. 1979.
Article
42. Sohn S, Chung CK, Park SH, Kim ES, Kim KJ, Kim CH. The fate of spinal schwannomas following subtotal resection: a retrospective multicenter study by the Korea spinal oncology research group. J Neurooncol. 114:345–351. 2013.
Article
43. Tacconi L, Johnston FG, Thomas DGT. Subependymoma of the cervical cord. Clin Neurol Neurosurg. 98:24–26. 1996.
Article
44. Takami T, Yamagata T, Ohata K. Posterolateral sulcus approach for spinal intramedullary tumor of lateral location: technical note. Neurol Med Chir (Tokyo). 53:920–927. 2013.
Article
45. Tan LA, Kasliwal MK, Mhanna N, Fontes RBV, Traynelis VC. Surgical resection of subependymoma of the cervical spinal cord. Neurosurg Focus. 37:Suppl 2. Video 3. 2014.
Article
46. Vaquero J, Martinez R, Vegazo I, Pontón P. Subependymoma of the cervical spinal cord. Neurosurgery. 24:625–627. 1989.
Article
47. Wu L, Yang T, Deng X, Yang C, Zhao L, Fang J, et al. Surgical outcomes in spinal cord subependymomas: an institutional experience. J Neurooncol. 116:99–106. 2014.
Article
48. Wu Z, Iwanami A, Yasuda A, Mikami S, Toyama Y, Nakamura M. Intramedullary cervicothoracic subependymoma: report of three cases and review of the literature. J Orthop Sci. 20:927–934. 2015.
Article
49. Zenmyo M, Ishido Y, Terahara M, Yamamoto T, Tanimoto A, Komiya S, et al. Intramedullary subependymoma of the cervical spinal cord: a case report with immunohistochemical study. Int J Neurosci. 120:676–679. 2010.
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr